Drug
Batoclimab
Batoclimab is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 33 (75.0%)
Trials by Status
terminated125%
completed250%
enrolling_by_invitation125%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_3
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
NCT05517447
completedphase_3
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
NCT05524571
enrolling_by_invitationphase_2
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT07188844
completedphase_3
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
NCT05517421
Clinical Trials (4)
Showing 4 of 4 trials
NCT05517447Phase 3
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
NCT05524571Phase 3
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
NCT07188844Phase 2
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT05517421Phase 3
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4